Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
AssigneeMorinda, Inc.
InventorsClaude Jarakae Jensen, Afa Kehaati Palu, Stephen P. Story, Summer Jensen, Chen Su
Life of this patent
Estimating the term…
Abstract
The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise an identified amount or concentration of a processed Morinda citrifolia product or an active ingredient there from, as obtained from the Indian Mulberry plant.
Claims9
A method for decreasing the proliferation of human colon adenocarcinoma cells, said method comprising:
- introducing to said human colon adenocarcinoma cells a composition comprising a processed Morinda citrifolia product present in an amount between about 0.01 and 100 percent by weight of the composition, said processed Morinda citrifolia product comprising the active ingredient Quercetin, wherein said processed Morinda citrifolia product is selected from the group consisting of Morinda citrifolia fruit juice, Morinda citrifolia puree juice, Morinda citrifolia puree, Morinda citrifolia fruit juice concentrate and Morinda citrifolia puree juice concentrate.
Dependencies are inferred from the claim text.